Nelli Erwin is the head of protein stability for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.
Seven Trends Shaping the Future of Pharmaceutical Formulation Development
Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.